Damora Therapeutics DMRA
NASDAQ DMRA
$24.15 +0.08 (+0.33%)
At close: Nov 10, 2026 · 4:00 PM EST

Damora Therapeutics (DMRA) Preferred Dividend Payments (2019 - 2020)

Updated

Damora Therapeutics' Preferred Dividend Payments was $2.71 million in Q3 2020, up 93.6% from $1.4 million a year earlier.

Analysis

Damora Therapeutics (DMRA) Preferred Dividend Payments (2019 - 2020) Analysis & Trends

For FY2019, Preferred Dividend Payments at Damora Therapeutics came in at $5.56 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Damora Therapeutics 1.49 Bn -364.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 2.71 Mn
Dec 31, 2019 1.40 Mn
Sep 30, 2019 1.40 Mn
API Access

Damora Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=DMRA&period=max&api_key=YOUR_API_KEY